{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T03:42:23Z","timestamp":1771731743600,"version":"3.50.1"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,5,15]]},"DOI":"10.2169\/internalmedicine.2159-23","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T22:55:33Z","timestamp":1697151333000},"page":"1465-1471","source":"Crossref","is-referenced-by-count":4,"title":["Disseminated Infection by &lt;i&gt;Scedosporium\/Lomentospora&lt;\/i&gt; during Induction Therapy for Acute Myeloid Leukemia Complicated by Nontuberculous Mycobacteria"],"prefix":"10.2169","volume":"63","author":[{"given":"Mari","family":"Kitahara","sequence":"first","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Sumi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Kazumoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Shishido","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimitsu","family":"Ueki","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Hiroshima","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiko","family":"Kamei","sequence":"additional","affiliation":[{"name":"Department of Medical Mycology Research Center, Chiba University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikaru","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Cortez KJ, Roilides E, Quiroz-Telles F, et al. Infections caused by <i>Scedosporium<\/i> spp. Clin Microbiol Rev 21: 157-197, 2008.","DOI":"10.1128\/CMR.00039-07"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Cooley L, Spelman D, Thursky K, Slavin M. Infection with <i>Scedosporium apiospermum<\/i> and <i>S. prolificans<\/i>, Australia. Emerg Infect Dis 13: 1170-1177, 2007.","DOI":"10.3201\/eid1308.060576"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Rodriguez-Tudela JL, Berenguer J, Guarro J, et al. Epidemiology and outcome of <i>Scedosporium prolificans<\/i> infection, a review of 162 cases. Med Mycol 47: 359-370, 2009.","DOI":"10.1080\/13693780802524506"},{"key":"4","unstructured":"4. Lackner M, de Hoog GS, Yang L, et al. Proposed nomenclature for <i>Pseudallescheria<\/i>, <i>Scedosporium<\/i> and related genera. Fungal Divers 67: 1-10, 2014."},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Caira M, Girmenia C, Valentini CG, et al. Scedosporiosis in patients with acute leukemia: a retrospective multicenter report. Haematologica 93: 104-110, 2008.","DOI":"10.3324\/haematol.11740"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Delhaes L, Harun A, Chen SC, et al. Molecular typing of Australian <i>Scedosporium<\/i> isolates showing genetic variability and numerous <i>S. aurantiacum<\/i>. Emerg Infect Dis 14: 282-290, 2008.","DOI":"10.3201\/eid1402.070920"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Husain S, Mu\u00f1oz P, Forrest G, et al. Infections due to <i>Scedosporium apiospermum<\/i> and <i>Scedosporium prolificans<\/i> in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis 40: 89-99, 2005.","DOI":"10.1086\/426445"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kunst H, Wickremasinghe M, Wells A, Wilson R. Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis. Eur Respir J 28: 352-357, 2006.","DOI":"10.1183\/09031936.06.00139005"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tamm M, Malouf M, Glanville A. Pulmonary scedosporium infection following lung transplantation. Transpl Infect Dis 3: 189-194, 2001.","DOI":"10.1034\/j.1399-3062.2001.30402.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Murayama T, Amitani R, Tsuyuguchi K, et al. Polypoid bronchial lesions due to <i>Scedosporium apiospermum<\/i> in a patient with <i>Mycobacterium avium<\/i> complex pulmonary disease. Eur Respir J 12: 745-747, 1998.","DOI":"10.1183\/09031936.98.12030745"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Caira M, Candoni A, Verga L, et al.; the SEIFEM Group. Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study). Haematologica 100: 284-292, 2015.","DOI":"10.3324\/haematol.2014.113399"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. DiNardo CD, Jonas BA, Pullarkat V, et al. Azacitidine and venetoclax in previously untreated acute myeloid leukemia. N Engl J Med 383: 617-629, 2020.","DOI":"10.1056\/NEJMoa2012971"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. On S, Rath CG, Lan M, et al. Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agent. Br J Haematol 197: 63-70, 2022.","DOI":"10.1111\/bjh.18051"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Wang J, Zhou M, Xu JY, Zhou RF, Chen B, Wan Y. Comparison of antifungal prophylaxis drugs in patients with hematological disease or undergoing hematopoietic stem cell transplantation: a systematic review and network meta-analysis. JAMA Netw Open 3: e2017652, 2020.","DOI":"10.1001\/jamanetworkopen.2020.17652"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mellinghoff SC, Panse J, Alakel N, et al. Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). Ann Hematol 97: 197-207, 2018.","DOI":"10.1007\/s00277-017-3196-2"},{"key":"16","unstructured":"16. Hoenigl M, Salmanton-Garc\u00eda J, Walsh TJ, et al. Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology. Lancet Infect Dis 21: e246-e257, 2021."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. McCarthy MW, Katragkou A, Iosifidis E, Roilides E, Walsh TJ. Recent advances in the treatment of scedosporiosis and fusariosis. J Fungi (Basel) 4: 73, 2018.","DOI":"10.3390\/jof4020073"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Troke P, Aguirrebengoa K, Arteaga C, et al.; the Global Scedosporium Study Group. Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients. Antimicrob Agents Chemother 52: 1743-1750, 2008.","DOI":"10.1128\/AAC.01388-07"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wu Y, Grossman N, Totten M, et al. Antifungal susceptibility profiles and drug resistance mechanisms of clinical <i>Lomentospora prolificans<\/i> isolates. Antimicrob Agents Chemother 64: e00318-e00320, 2020.","DOI":"10.1128\/AAC.00318-20"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Seidel D, Mei\u00dfner A, Lackner M, et al. Prognostic factors in 264 adults with invasive <i>Scedosporium<\/i> spp. and <i>Lomentospora prolificans<\/i> infection reported in the literature and FungiScope<sup>\u00ae<\/sup>. Crit Rev Microbiol 45: 1-21, 2019.","DOI":"10.1080\/1040841X.2018.1514366"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Yamashita D, Wada K, Yoshimuta T, et al. Drug interaction between voriconazole and rifampicin after discontinuation of rifampicin: a case report. Iryou Yakugaku (Jpn J Pharm Health Care Sci) 36: 323-327, 2010 (in Japanese, Abstract in English).","DOI":"10.5649\/jjphcs.36.323"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Miwa S, Shirai M, Toyoshima M, et al. Efficacy of clarithromycin and ethambutol for <i>Mycobacterium avium<\/i> complex pulmonary disease. A preliminary study. Ann Am Thorac Soc 11: 23-29, 2014.","DOI":"10.1513\/AnnalsATS.201308-266OC"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/10\/63_2159-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T03:27:13Z","timestamp":1716002833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/10\/63_2159-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2159-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,15]]},"article-number":"2159-23"}}